Treatment of Vasomotor Symptoms
AssigneeSprout Pharmaceuticals, Inc.
InventorsVladimir Hanes, Annelies Verbeek
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the treatment of vasomotor symptoms comprising the administration of a therpeutically effective amount of flibanserin.
Claims14
A method for the treatment of vasomotor symptoms comprising the administration of a therapeutically effective amount of flibanserin, or a pharmacologically acceptable acid addition salt, hydrate, or solvate, thereof.
The method according to any one of the claim 1 to 9 or 13 or 14, wherein the flibanserin is administered as a pharmaceutically acceptable acid addition salt selected from the salts formed by succinic acid, hydrobromic acid, acetic acid, fumaric acid, maleic acid, methanesulphonic acid, lactic acid, phosphoric acid, hydrochloric acid, sulphuric acid, tartaric acid, citric acid, and mixtures thereof.
The method according to any one of the claim 1 to 9 or 13 or 14, wherein the flibanserin is administered as flibanserin polymorph A.
The method according to any one of the claim 1 to 9 or 13 or 14, wherein the flibanserin is administered in a dose range between 0.1 to 400 mg per day.
Dependencies are inferred from the claim text.